Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.
about
Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.Diagnosis of genital herpes simplex virus infection in the clinical laboratoryPerformance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescentsEvaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection.Genital herpes: review of the epidemic and potential use of type-specific serologyVariability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1.Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.Recent advances in management of genital herpes.Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolatesDetection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.Sorting out the new HSV type specific antibody tests.Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum.Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women.Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UKEstimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancySecreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serologyProduction of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 InfectionPrevalence of herpes simplex virus types 1 and 2 and associated sociodemographic variables in pregnant women attending king fahd hospital of the universityEvaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposureAntibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophreniaHSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.Genital herpes, "the new paradigm"Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.Comparison of a multiplexed herpes simplex virus type-specific immunoglobulin G serology assay to immunoblot, Western blot, and enzyme-linked immunosorbent assays.Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.Seroprevalence of herpes simplex virus-type 2 in African-American college women.
P2860
Q33550768-9D501C87-E27D-45A3-BA68-8EDE8AAF28A0Q33655295-C70F0C1B-FE86-4CD7-A54C-59A6593D2DBDQ33944535-BF010A0B-FD82-4E49-B949-2AC489F343B4Q33959969-B7DD1B9F-A3BC-454F-82CA-0D803A65AC68Q33960473-174CE58C-C50A-48B4-9996-82B344A332CAQ33975387-00885EA7-FE01-4C8C-B2F9-08253062A112Q33997967-8B0E9584-2448-4D59-A2B4-05528351E963Q33998516-4548B611-26F8-4A25-BEF7-22DBD9726B62Q34012149-D0CBCF9D-999A-4DD9-9ADF-38E6D2106F3FQ34193783-EA47714B-ECAD-47DA-94A8-882C412590F5Q34202179-314BB552-A4EF-44D1-B78F-29EEAFB13D6AQ34313806-AD21266C-D214-40AB-B8E7-7328DDAF0C45Q34720324-BA4C97AA-5F13-4A14-B2D1-2E3C424D1F1DQ34751818-16F98EBE-AA77-4122-B086-897AEEBB56ACQ34942862-372ABF3D-04AA-4D1F-B84C-3B4D8639059BQ35528485-E826D6A0-410F-4B8B-A734-DB0B2D98A85EQ35529272-E2EC53A8-CB4B-4187-9602-A32E7638E291Q35530334-2D777182-FBD4-4CEA-8C3C-48C1CD65C2A6Q35530369-656CD4A9-997A-480B-ADFB-BC7281EFF3AFQ35562480-69475032-2EFA-4414-B4E5-7DBCDDD764E5Q35639039-0A61A8CB-BD40-4BC2-A6FD-24239E47A1F1Q35749539-EC0341B5-4014-4538-B5E8-00B314E2DC53Q36034465-0F9495C6-901B-4068-A637-DD39FE2D24DAQ36134113-401EEEFB-3290-4AB4-80C7-4053B15343B9Q36386350-A765B838-54CE-4582-B34A-E3DEB26C71E1Q37041949-20503A50-3DE1-45DA-8B01-145BE61AF482Q37043264-5546FCB6-72D2-4C84-8CE8-1827172B531AQ37229406-088D6133-3C82-42A8-82A9-A66C22D52EB7Q39462534-3FE8C08A-FCB2-4D08-BC38-E43F23451A93Q39627888-A661CA1D-1E29-4EA0-947C-7529145FE6CDQ42170630-CFB107E5-8829-47DF-9AAF-E4AA8EF744E6Q43117859-C1BF9D18-503A-46EC-B230-E89399877AB5Q45749366-0CE66672-132E-4FE3-B2F4-CFDFFD60CD0B
P2860
Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Premarket evaluation of a comm ...... irus type-specific antibodies.
@ast
Premarket evaluation of a comm ...... irus type-specific antibodies.
@en
Premarket evaluation of a comm ...... irus type-specific antibodies.
@nl
type
label
Premarket evaluation of a comm ...... irus type-specific antibodies.
@ast
Premarket evaluation of a comm ...... irus type-specific antibodies.
@en
Premarket evaluation of a comm ...... irus type-specific antibodies.
@nl
prefLabel
Premarket evaluation of a comm ...... irus type-specific antibodies.
@ast
Premarket evaluation of a comm ...... irus type-specific antibodies.
@en
Premarket evaluation of a comm ...... irus type-specific antibodies.
@nl
P2093
P2860
P1476
Premarket evaluation of a comm ...... virus type-specific antibodies
@en
P2093
P2860
P304
P407
P577
1998-01-01T00:00:00Z